Lucy Scientific Discovery (LSDI) Stock Price, News & Analysis

Company Overview

Lucy Scientific Discovery Inc., an early stage psychotropics contract manufacturing company, engaged in the research, manufacturing, and commercialization of psychedelic products. The company offers biological raw materials, active pharmaceutical ingredients (APIs), and finished biopharmaceutical products. It also develops and produces highly controlled agricultural grow environments for plant manufacturing and replication applications. The company was formerly known as Hollyweed North Cannabis Inc. and changed its name to Lucy Scientific Discovery Inc. in May 2021. Lucy Scientific Discovery Inc. was incorporated in 2017 and is headquartered in Victoria, Canada.

Key Stats

• Today's Range: N/A
• 50-Day Range: $0.00 to $0.51
• 52-Week Range: N/A
• Volume: 314,500 shs
• Average Volume: 640,390 shs
• Market Capitalization: $907,000.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LSDI Stock Analysis - Frequently Asked Questions

When did Lucy Scientific Discovery's stock split?

Shares of Lucy Scientific Discovery reverse split on Monday, February 26th 2024. The 1-10 reverse split was announced on Monday, February 26th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, February 26th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

When did Lucy Scientific Discovery IPO?

Lucy Scientific Discovery (LSDI) raised $8 million in an initial public offering on Thursday, February 9th 2023. The company issued 2,000,000 shares at a price of $4.00 per share. WestPark Capital acted as the underwriter for the IPO.

What other stocks do shareholders of Lucy Scientific Discovery own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Lucy Scientific Discovery investors own include Sunworks (SUNW), Applied DNA Sciences (APDN), Ascent Solar Technologies (ASTI), Meta Platforms (META), Energy Transfer (ET), Intel (INTC) and NIO (NIO).

Company Calendar

• Today: 2/05/2025
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:LSDI
• CUSIP: N/A
• CIK: 1865127
• Web: www.lucyscientific.com
• Phone: 778-410-5195
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($7.00)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-8,990,000.00
• Net Margins: N/A
• Pretax Margin: -105.86%
• Return on Equity: -294.74%
• Return on Assets: -137.65%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.38
• Quick Ratio: 0.38

Sales & Book Value

• Annual Sales: $16,732.00
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $2.86 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,765,000
• Free Float: N/A
• Market Cap: $907,000.00
• Optionable: Not Optionable
• Beta: 1.41